| 查看: 252 | 回复: 0 | |||
lubenle铁杆木虫 (正式写手)
|
[交流]
FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用
|
|
Use of Aspirin for Primary Prevention of Heart Attack and Stroke http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用， 但对于有心脏病或中风史的人服用阿斯匹灵有预防再次发作的作用！ [05/02/2014] Cardiovascular disease, including heart disease and stroke, affects tens of millions of people in the United States. Consumers and patients who do not suffer from cardiovascular disease sometimes consider taking aspirin to reduce the possibility of having a heart attack or stroke. Reducing the possibility of having a first heart attack or stroke is called primary prevention. The FDA has reviewed the available data and does not believe the evidence supports the general use of aspirin for primary prevention of a heart attack or stroke. In fact, there are serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain, in situations where the benefit of aspirin for primary prevention has not been established. The available evidence supports the use of aspirin for preventing another heart attack or stroke in patients who have cardiovascular disease or who have already had a heart attack or stroke. Reducing the risk of additional heart attacks or strokes is known as secondary prevention. In patients who have had a cardiovascular event, the known benefits of aspirin for secondary prevention outweigh the risk of bleeding. |
回复此楼» 猜你喜欢
申请书提交后，您还认真地看过本子没有，发现了哪些问题？
已经有39人回复
-
中了！写在23年放榜之后，以及一点小感触
已经有80人回复
-
放射医学论文润色/翻译怎么收费?
已经有99人回复
-
医学考研调剂
已经有1人回复
-
349药学专硕341找调剂，A区B区线均过
已经有5人回复
-
求导师推荐 夏令营提前联系导师
已经有0人回复
-
文献求助，急急急！！！！
已经有2人回复
